Phase 2 Study of Oral Epetraborole in Adults With Polycythemia Vera
Study sponsor: AN2 Therapeutics, Inc · ANTX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2029-04Estimated
Enrollment · participants75Estimated
Source updated2026-10-23Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.